Disruptive Pharma AB

5LH0

Company Profile

  • Business description

    Disruptive Pharma AB is a Swedish pharmaceutical technology company engaged in developing and commercializing Formulite, a patented drug delivery platform based on mesoporous magnesium carbonate (MMC). The platform is designed to improve the solubility, oral bioavailability and other properties of pharmaceutical compounds. The company operates through contract development, strategic partnerships, and licensing arrangements with pharmaceutical and biotechnology companies to develop and commercialize drug products using Formulite technology.

  • Contact

    Dag Hammarskjolds vag 54B
    Uppsala Science Park
    Uppsala751 83
    SWE

    T: +46 735685329

    https://www.disruptivepharma.se

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

Stocks News & Analysis

stocks

Why don’t good returns guarantee a 5-star rating?

Amy Arnott explains how Morningstar’s stock ratings work.
stocks

Despite post earnings rally ASX share still cheap

Lifting our 2028 earnings estimate by 20%.
stocks

Overvalued ASX share has overly ambitious profit target

We think the new profit target is aggressive and unlikely to be met.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,997.30168.10-1.83%
CAC 408,216.78135.22-1.62%
DAX 4026,045.37553.27-2.08%
Dow JONES (US)50,764.98843.19-1.63%
FTSE 10010,689.87191.68-1.76%
HKSE23,508.17245.67-1.03%
NASDAQ24,251.97257.79-1.05%
Nikkei 22558,860.43801.59-1.34%
NZX 50 Index14,306.963.190.02%
S&P 5007,328.4588.14-1.19%
S&P/ASX 2008,883.20161.50-1.79%
SSE Composite Index3,584.5817.99-0.50%

Market Movers